PledPharma AB | |
Stock Exchange | First North Sweden |
EPS |
SEK2.2 |
Market Cap |
SEK878.43 M |
Shares Outstanding |
48.67 M |
Public Float |
25.11 M |
Address |
Grev Turegatan 11C Stockholm AB 114 46 Sweden |
Employees | - |
Website | http://www.pledpharma.se |
Updated | 09/14/2018 |
PledPharma AB operates as a pharmaceutical company, which engages in the development of new drugs that protect the body against oxidative stress, a potentially disabling and sometimes life-threatening condition that can be caused by chemotherapy treatment and acetaminophen (paracetamol) poisoning. It offers the PledOx which reduces nerve damage associated with chemotherapy. The company was founded by Torsten Almén, Heidi Brurok, Louis J. |